cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2005; 45:1748-1752, doi:10.1016/j.jacc.2005.01.058
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (79)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenaweser, P.
Right arrow Articles by Hess, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenaweser, P.
Right arrow Articles by Hess, O. M.
Related Collections
Right arrowRelated Article

Stent Thrombosis Is Associated With an Impaired Response to Antiplatelet Therapy

Peter Wenaweser, MD*, Janine Dörffler-Melly, MD, PhD{dagger}, Katja Imboden, BA*, Stephan Windecker, MD*, Mario Togni, MD*, Bernhard Meier, MD*, Andre Haeberli, MD{ddagger} and Otto M. Hess, MD*,*

* Department of Cardiology, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland
{dagger} Department of Angiology, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland
{ddagger} Department of Clinical Research, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland



View larger version (14K):

[in a new window]
 
Figure 1 Platelet aggregation (top: 5 µmol adenosine diphosphate [ADP]; middle: 20 µmol ADP) in patients with stent thrombosis (ST), control patients, and volunteers. Black boxes = acetylsalicyclic acid (ASA) (100 mg daily) alone; white boxes = ASA plus clopidogrel (75 mg daily). Platelet aggregation (bottom: 0.5 mg/ml arachionic acid) on ASA (100 mg daily) in patients with ST, control patients, and volunteers.

 


View larger version (16K):

[in a new window]
 
Figure 2 Resistance to acetylsalicyclic acid (ASA) (top: 0.5 mg/ml arachionic acid, defined as ≥20% maximal platelet aggregation). Clopidogrel resistance (middle: 5 µmol/l adenosine diphosphate, defined as relative change between aggregation under ASA and ASA plus clopidogrel <10%). Acetylsalicyclic acid and/or clopidogrel resistance (bottom: combined results of the top and middle panels). ns = not significant; ST = stent thrombosis.

 




 
  cardiology careers collections past issues search home